Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q3 2025 vs. Q2 2025
How the institutions holding Kiora Pharmaceuticals Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 16 | 17 | +1 |
| Shares | 931.8K | 616.2K | −315.7K (−33.9%) |
| Value | $2.68M | $1.71M | −$969.0K (−36.1%) |
New holders (5)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 44,573 | $124.8K | 0.00% |
| DRW Securities, LLC | 36,865 | $102.5K | 0.01% |
| Vanguard Group Inc | 20,915 | $58.6K | 0.00% |
| Renaissance Technologies LLC | 12,400 | $34.5K | 0.00% |
| Two Sigma Investments, LP | 11,984 | $33.3K | 0.00% |
Sold out (4)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| AIGH Capital Management LLC | 216,345 | $623.1K |
| Velan Capital Investment Management LP | 122,223 | $352.0K |
| Tower Research Capital LLC (TRC) | 439 | $1.26K |
| Raymond James Financial Inc | 2 | $6 |